The latest cancer drugs news
Browsing: Cancer Drug News
Double trouble for drug-resistant cancers
ETC-159, a made-in-Singapore anti-cancer drug that is currently in early phase clinical trials for use…
Three-drug combination moves forward for advanced breast cancer
A combination of three drugs is safe and shows signs of effectiveness in treating some…
Proteomics analysis identifies potential drug targets for aggressive human cancers
Researchers at Baylor College of Medicine, USA, show that analysis of the proteomics, or all…
Predicting success in therapy with individualised cancer models
In the EU alone, 78,800 men died of prostate cancer last year. While tumours discovered…
Dual-targeting drug for EBV-related cancers
A Hong Kong Baptist University-led (HKBU) research team has developed a novel drug which has…
Researchers watch anti-cancer drug release from DNA nanostructures in real time
DNA nanotechnology – the research field using DNA molecules as building material – has developed…
Targeted delivery of highly toxic anti-cancer drug to brain tumours
With a survival rate of only five years, the most common and aggressive form of…
Tucatinib authorised by UK’s MHRA for locally advanced or metastatic HER2-positive breast cancer
Seagen UK Ltd. today announced that the UK Medicines and Healthcare products Regulatory Agency (MHRA)…
Antihypertensives can decrease bleomycin-induced lung injury
Bleomycin is a drug used to treat certain cancers, such as Hodgkin lymphoma and germ…
New classification: leukaemia subtypes reveal potential of existing drugs
Using advanced RNA sequencing, scientists have identified two unique subtypes of a prominent mutation present…